Perspective Therapeutics (CATX) EBT (2010 - 2026)

Perspective Therapeutics recorded quarterly EBT of -$26.2 million in Q1 2026, down 139.59% quarter-over-quarter from $66.1 million in Q4 2025, and down 44.08% year-over-year from -$46.8 million in Q1 2025.

Perspective Therapeutics' EBT history runs 17 years deep, the most recent figure standing at -$26.2 million for Q1 2026.

  • In Q1 2026, EBT fell 44.08% year-over-year to -$26.2 million; the TTM figure through Mar 2026 stood at -$8.0 million (up 90.72% YoY), while the FY2024 annual figure was -$80.0 million, down 99.44% from the prior year.
  • EBT came in at -$26.2 million for Q1 2026 at Perspective Therapeutics, down from $66.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $66.1 million in Q4 2025 to a low of -$41.8 million in Q4 2024.
  • A 5-year average of -$9.5 million and a median of -$11.1 million in 2023 frame the typical range for EBT.
  • Across the five-year window, EBT slumped 707.05% in 2023 and surged 258.14% in 2025, its largest moves.
  • Perspective Therapeutics' EBT stood at -$7.3 million in 2022, then fell by 5.97% to -$7.8 million in 2023, then plunged by 438.12% to -$41.8 million in 2024, then soared by 258.14% to $66.1 million in 2025, then slumped by 139.59% to -$26.2 million in 2026.
  • According to Business Quant data, EBT over the past three periods registered -$26.2 million, $66.1 million, and -$26.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.45 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 850.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.40 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.16 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 459.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 222.44 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 269.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 505.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 304.50 Mn
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -26.19 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -26.19 Mn
Dec 31, 2025 66.15 Mn
Sep 30, 2025 -25.97 Mn
Jun 30, 2025 -22.00 Mn
Mar 31, 2025 -18.18 Mn
Dec 31, 2024 -41.83 Mn
Sep 30, 2024 -15.12 Mn
Jun 30, 2024 -11.21 Mn
Mar 31, 2024 -11.83 Mn
Dec 31, 2023 -7.77 Mn
Sep 30, 2023 -10.36 Mn
Jun 30, 2023 -11.11 Mn
Mar 31, 2023 -10.87 Mn
Dec 31, 2022 -7.34 Mn
Sep 30, 2022 -4.07 Mn
Jun 30, 2022 -2.08 Mn
Mar 31, 2022 -1.35 Mn
Dec 31, 2021 -1.60 Mn
Sep 30, 2021 -2.24 Mn
Jun 30, 2021 1.35 Mn
Mar 31, 2021 -745,000.00
Dec 31, 2020 -868,000.00
Sep 30, 2020 -713,000.00
Jun 30, 2020 -1.19 Mn
Mar 31, 2020 -545,000.00
Dec 31, 2019 -897,000.00
Sep 30, 2019 -816,000.00
Jun 30, 2019 -1.10 Mn
Mar 31, 2019 -1.13 Mn
Dec 31, 2018 -1.41 Mn
Sep 30, 2018 -1.51 Mn
Jun 30, 2018 -2.36 Mn
Mar 31, 2018 -1.33 Mn
Dec 31, 2017 -1.46 Mn
Sep 30, 2017 -1.55 Mn
Jun 30, 2017 -1.84 Mn
Mar 31, 2017 -1.36 Mn
Dec 31, 2016 -1.45 Mn
Sep 30, 2016 -1.55 Mn
Jun 30, 2016 -1.20 Mn
Mar 31, 2016 -1.27 Mn
Dec 31, 2015 -1.35 Mn
Sep 30, 2015 -1.04 Mn
Jun 30, 2015 -1.03 Mn
Mar 31, 2015 -982,158.00
Dec 31, 2014 -947,954.00
Sep 30, 2014 -1.09 Mn
Jun 30, 2014 -1.31 Mn
Mar 31, 2014 -988,439.00
Dec 31, 2013 -1.04 Mn
Sep 30, 2013 -1.23 Mn
Jun 30, 2013 -1.02 Mn
Mar 31, 2013 -824,037.00
Dec 31, 2012 -1.10 Mn
Sep 30, 2012 -1.12 Mn
Jun 30, 2012 -995,864.00
Mar 31, 2012 -765,981.00
Dec 31, 2011 -794,745.00
Sep 30, 2011 -1.10 Mn
Jun 30, 2011 -788,997.00
Mar 31, 2011 -867,265.00
Dec 31, 2010 -648,069.00
Sep 30, 2010 -871,882.00